Progranulin axis and recent developments in frontotemporal lobar degeneration

Alzheimer's Research and Therapy

Volumn 4, Issue 1, 2012, Pages

  Nicholson, Alexandra M ^a   Gass, Jennifer ^a   Petrucelli, Leonard ^a   Rademakers, Rosa ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRANULIN;

CELL CULTURE; CENTRAL NERVOUS SYSTEM; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HAPLOINSUFFICIENCY; HUMAN; INTRACELLULAR SIGNALING; NERVE DEGENERATION; NERVE GROWTH; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SYNAPTIC TRANSMISSION;

EID: 84855219552     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt102     Document Type: Review

References (80)

1. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF, Neurology 1998 51 1546 1554 9855500
2. The prevalence of frontotemporal dementia. Ratnavalli E, Brayne C, Dawson K, Hodges JR, Neurology 2002 58 1615 1621 12058088 (Pubitemid 34602891)
3. Clinical features of frontotemporal dementia. Boxer AL, Miller BL, Alzheimer Dis Assoc Disord 2005 19 Suppl 1 3 S6 16317256
4. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ, Arch Neurol 2001 58 1803 1809 10.1001/archneur.58.11.1803 11708987 (Pubitemid 33044246)
5. Classification of primary progressive aphasia and its variants. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam MM, Grossman M, Neurology 2011 76 1006 1014 10.1212/WNL.0b013e31821103e6 21325651
6. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Lomen-Hoerth C, Anderson T, Miller B, Neurology 2002 59 1077 1079 12370467
7. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Mackenzie IR, Baker M, Pickering-Brown S, Hsiung GY, Lindholm C, Dwosh E, Gass J, Cannon A, Rademakers R, Hutton M, Feldman HH, Brain 2006 129 3081 3090 10.1093/brain/awl271 17071926 (Pubitemid 44684527)
8. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM, Science 2006 314 130 133 10.1126/science.1134108 17023659 (Pubitemid 44547757)
9. The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. Buratti E, Baralle FE, RNA Biol 2010 7 420 429 10.4161/rna.7.4.12205 20639693
10. The Genetics of FTD: Should You Worry? http://www.theaftd.org/ frontotemporal-degeneration/genetics
11. Association of missense and 5'-splicesite mutations in tau with the inherited dementia FTDP-17. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Che LK, Norton J, Morris JC, Reed LA, Trojanowski J, Basun H, et al. Nature 1998 393 702 705 10.1038/31508 9641683 (Pubitemid 28289662)
12. Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies. Spillantini MG, Bird TD, Ghetti B, Brain Pathol 1998 8 387 402 9546295 (Pubitemid 28186074)
13. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE, Nat Genet 2004 36 377 381 10.1038/ng1332 15034582 (Pubitemid 38437260)
14. Mutant valosin-containing protein causes a novel type of frontotemporal dementia. Schroder R, Watts GD, Mehta SG, Evert BO, Broich P, Fliessbach K, Pauls K, Hans VH, Kimonis V, Thal DR, Ann Neurol 2005 57 457 461 10.1002/ana.20407 15732117 (Pubitemid 40343972)
15. Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Borroni B, Bonvicini C, Alberici A, Buratti E, Agosti C, Archetti S, Papetti A, Stuani C, Di Luca M, Gennarelli M, Padovani A, Hum Mutat 2009 30 974 E983 10.1002/humu.21100 19655382
16. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Benajiba L, Le Ber I, Camuzat A, Lacoste M, Thomas-Anterion C, Couratier P, Legallic S, Salachas F, Hannequin D, Decousus M, Lacomblez L, Guedj E, Golfier V, Camu W, Dubois B, Campion D, Meininger V, Brice A, Ann Neurol 2009 65 470 473 10.1002/ana.21612 19350673
17. De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis. Dejesus-Hernandez M, Kocerha J, Finch N, Crook R, Baker M, Desaro P, Johnston A, Rutherford N, Wojtas A, Kennelly K, Wszolek ZK, Graff-Radford N, Boylan K, Rademakers R, Hum Mutat 2010 31 1377 E1389 10.1002/humu.21241 20232451
18. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, et al. Neuron 2011 72 257 268 10.1016/j.neuron.2011.09.010 21944779
19. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, Dickson D, Berger Z, Eriksen J, Robinson T, Zehr C, Dickey CA, Crook R, McGowan E, Mann D, Boeve B, Feldman H, Hutton M, Nature 2006 442 916 919 10.1038/nature05016 16862116 (Pubitemid 44285946)
20. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, Rademakers R, Vandenberghe R, Dermaut B, Martin JJ, van Duijn C, Peeters K, Sciot R, Santens P, De Pooter T, Mattheijssens M, Van den Broeck M, Cuijt I, Vennekens K, De Deyn PP, Kumar-Singh S, Van Broeckhoven C, Nature 2006 442 920 924 10.1038/nature05017 16862115 (Pubitemid 44285947)
21. A harmonized classification system for FTLD-TDP pathology. Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, Perry RH, Trojanowski JQ, Mann DM, Lee VM, Acta Neuropathol 2011 122 111 113 10.1007/s00401-011-0845-8 21644037
22. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, Crook R, Melquist S, Kuntz K, Petersen R, Josephs K, Pickering-Brown SM, Graff-Radford N, Uitti R, Dickson D, Wszolek Z, Gonzalez J, Beach TG, Bigio E, Johnson N, Weintraub S, Mesulam M, White CL, Woodruff B, Caselli R, Hsiung GY, Feldman H, Knopman D, Hutton M, Rademakers R, Hum Mol Genet 2006 15 2988 3001 10.1093/hmg/ddl241 16950801 (Pubitemid 44530703)
23. Isolation and sequence of the granulin precursor cDNA from human bone marrow reveals tandem cysteine-rich granulin domains. Bhandari V, Palfree RG, Bateman A, Proc Natl Acad Sci USA 1992 89 1715 1719 10.1073/pnas.89.5.1715 1542665
24. Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo. He Z, Bateman A, Cancer Res 1999 59 3222 3229 10397269 (Pubitemid 29316026)
25. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Zhu J, Nathan C, Jin W, Sim D, Ashcroft GS, Wahl SM, Lacomis L, Erdjument- Bromage H, Tempst P, Wright CD, Ding A, Cell 2002 111 867 878 10.1016/S0092-8674(02)01141-8 12526812 (Pubitemid 36106407)
26. Progranulin: normal function and role in neurodegeneration. Eriksen JL, Mackenzie IR, J Neurochem 2008 104 287 297 17953663 (Pubitemid 350293866)
27. Progranulin in frontotemporal lobar degeneration and neuroinflammation. Ahmed Z, Mackenzie IR, Hutton ML, Dickson DW, J Neuroinfl amm 2007 4 7 10.1186/1742-2094-4-7 (Pubitemid 46351578)
28. Cellular localization of gene expression for progranulin. Daniel R, He Z, Carmichael KP, Halper J, Bateman A, J Histochem Cytochem 2000 48 999 1009 10.1177/002215540004800713 10858277 (Pubitemid 30421564)
29. Progranulin (acrogranin/PC cellderived growth factor/granulin-epithelin precursor) is expressed in the placenta, epidermis, microvasculature, and brain during murine development. Daniel R, Daniels E, He Z, Bateman A, Dev Dyn 2003 227 593 599 10.1002/dvdy.10341 12889069 (Pubitemid 36951084)
30. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. Kessenbrock K, Frohlich L, Sixt M, Lammermann T, Pfister H, Bateman A, Belaaouaj A, Ring J, Ollert M, Fassler R, Jenne DE, J Clin Invest 2008 118 2438 2447 18568075 (Pubitemid 351949772)
31. The granulin/epithelin precursor abrogates the requirement for the insulin-like growth factor 1 receptor for growth in vitro. Xu SQ, Tang D, Chamberlain S, Pronk G, Masiarz FR, Kaur S, Prisco M, Zanocco- Marani T, Baserga R, J Biol Chem 1998 273 20078 20083 10.1074/jbc.273.32.20078 9685348 (Pubitemid 28377561)
32. Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival. Van Damme P, Van Hoecke A, Lambrechts D, Vanacker P, Bogaert E, van Swieten J, Carmeliet P, Van Den Bosch L, Robberecht W, J Cell Biol 2008 181 37 41 10.1083/jcb.200712039 18378771 (Pubitemid 351519762)
33. Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3 Gao X, Joselin AP, Wang L, Kar A, Ray P, Bateman A, Goate AM, Wu JY, Protein Cell 2010 1 552 562 10.1007/s13238-010-0067-1 21204008
34. Granulin mutations associated with frontotemporal lobar degeneration and related disorders: an update. Gijselinck I, Van Broeckhoven C, Cruts M, Hum Mutat 2008 29 1373 1386 10.1002/humu.20785 18543312 (Pubitemid 352774891)
35. Alzheimer Disease & Frontotemporal Dementia Mutation Database. http://www.molgen.ua.ac.be/ftdmutations/
36. Progranulin locus deletion in frontotemporal dementia. Gijselinck I, van der Zee J, Engelborghs S, Goossens D, Peeters K, Mattheijssens M, Corsmit E, Del-Favero J, De Deyn PP, Van Broeckhoven C, Cruts M, Hum Mutat 2008 29 53 58 10.1002/humu.20651 18157829
37. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitinpositive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Mukherjee O, Pastor P, Cairns NJ, Chakraverty S, Kauwe JS, Shears S, Behrens MI, Budde J, Hinrichs AL, Norton J, Levitch D, Taylor-Reinwald L, Gitcho M, Tu PH, Tenenholz Grinberg L, Liscic RM, Armendariz J, Morris JC, Goate AM, Ann Neurol 2006 60 314 322 10.1002/ana.20963 16983685 (Pubitemid 44520234)
38. Recent insights into the molecular genetics of dementia. Rademakers R, Rovelet-Lecrux A, Trends Neurosci 2009 32 451 461 10.1016/j.tins.2009.05.005 19640594
39. Novel PSEN1 and PGRN mutations in early-onset familial frontotemporal dementia. Bernardi L, Tomaino C, Anfossi M, Gallo M, Geracitano S, Costanzo A, Colao R, Puccio G, Frangipane F, Curcio SA, Mirabelli M, Smirne N, Iapaolo D, Maletta RG, Bruni AC, Neurobiol Aging 2009 30 1825 1833 10.1016/j. neurobiolaging.2008.01.005 18314228
40. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease. Brouwers N, Sleegers K, Engelborghs S, Maurer-Stroh S, Gijselinck I, van der Zee J, Pickut BA, Van den Broeck M, Mattheijssens M, Peeters K, Schymkowitz J, Rousseau F, Martin JJ, Cruts M, De Deyn PP, Van Broeckhoven C, Neurology 2008 71 656 664 10.1212/01.wnl.0000319688.89790.7a 18565828
41. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Finch N, Baker M, Crook R, Swanson K, Kuntz K, Surtees R, Bisceglio G, Rovelet-Lecrux A, Boeve B, Petersen RC, Dickson DW, Younkin SG, Deramecourt V, Crook J, Graff-Radford NR, Rademakers R, Brain 2009 132 583 591 10.1093/brain/awn352 19158106
42. Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion. Shankaran SS, Capell A, Hruscha AT, Fellerer K, Neumann M, Schmid B, Haass C, J Biol Chem 2008 283 1744 1753 17984093
43. Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia. van der Zee J, Le Ber I, Maurer-Stroh S, Engelborghs S, Gijselinck I, Camuzat A, Brouwers N, Vandenberghe R, Sleegers K, Hannequin D, Dermaut B, Schymkowitz J, Campion D, Santens P, Martin JJ, Lacomblez L, De Pooter T, Peeters K, Mattheijssens M, Vercelletto M, Van den Broeck M, Cruts M, De Deyn PP, Rousseau F, Brice A, Van Broeckhoven C, Hum Mutat 2007 28 416 17345604
44. Pathogenic cysteine mutations affect progranulin function and production of mature granulins. Wang J, Van Damme P, Cruchaga C, Gitcho MA, Vidal JM, Seijo-Martinez M, Wang L, Wu JY, Robberecht W, Goate A, J Neurochem 2010 112 1305 1315 10.1111/j.1471-4159.2009.06546.x 20028451
45. Common variation in the miR-659 bindingsite of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, Lincoln SJ, Finch N, Rutherford NJ, Crook RJ, Josephs KA, Boeve BF, Knopman DS, Petersen RC, Parisi JE, Caselli RJ, Wszolek ZK, Uitti RJ, Feldman H, Hutton ML, Mackenzie IR, Graff-Radford NR, Dickson DW, Hum Mol Genet 2008 17 3631 3642 10.1093/hmg/ddn257 18723524
46. No association of PGRN 3'UTR rs5848 in frontotemporal lobar degeneration. Rollinson S, Rohrer JD, van der Zee J, Sleegers K, Mead S, Engelborghs S, Collinge J, De Deyn PP, Mann DM, Van Broeckhoven C, Pickering-Brown SM, Neurobiol Aging 2011 32 754 755 10.1016/j.neurobiolaging.2009.04.009 19446372
47. Variation at GRN 3'-UTR rs5848 is not associated with a risk of frontotemporal lobar degeneration in Dutch population. Simon-Sanchez J, Seelaar H, Bochdanovits Z, Deeg DJ, van Swieten JC, Heutink P, PLoS One 2009 4 7494 10.1371/journal.pone.0007494 19847305
48. Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly. Dickson DW, Baker M, Rademakers R, Neurodegener Dis 2010 7 170 174 10.1159/000289231 20197700
49. rs5848 variant of progranulin gene is a risk of Alzheimer's disease in the Taiwanese population. Lee MJ, Chen TF, Cheng TW, Chiu MJ, Neurodegener Dis 2011 8 216 220 10.1159/000322538 21212639
50. An association study between granulin gene polymorphisms and Alzheimer's disease in Finnish population. Viswanathan J, Makinen P, Helisalmi S, Haapasalo A, Soininen H, Hiltunen M, Am J Med Genet B Neuropsychiatr Genet 2009 150B 747 750 10.1002/ajmg.b.30889 19016491
51. Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Sleegers K, Brouwers N, Maurer-Stroh S, van Es MA, Van Damme P, van Vught PW, van der Zee J, Serneels S, De Pooter T, Van den Broeck M, Cruts M, Schymkowitz J, De Jonghe P, Rousseau F, van den Berg LH, Robberecht W, Van Broeckhoven C, Neurology 2008 71 253 259 10.1212/01.wnl.0000289191.54852.75 18184915
52. GRN variability contributes to sporadic frontotemporal lobar degeneration. Galimberti D, Fenoglio C, Cortini F, Serpente M, Venturelli E, Villa C, Clerici F, Marcone A, Benussi L, Ghidoni R, Gallone S, Scalabrini D, Restelli I, Boneschi FM, Cappa S, Binetti G, Mariani C, Rainero I, Giordana MT, Bresolin N, Scarpini E, J Alzheimers Dis 2010 19 171 177 20061636
53. Progranulin is expressed within motor neurons and promotes neuronal cell survival. Ryan CL, Baranowski DC, Chitramuthu BP, Malik S, Li Z, Cao M, Minotti S, Durham HD, Kay DG, Shaw CA, Bennett HP, Bateman A, BMC Neurosci 2009 10 130 10.1186/1471-2202-10-130 19860916
54. Progranulin deficiency decreases gross neural connectivity but enhances transmission at individual synapses. Tapia L, Milnerwood A, Guo A, Mills F, Yoshida E, Vasuta C, Mackenzie IR, Raymond L, Cynader M, Jia W, Bamji SX, J Neurosci 2011 31 11126 11132 10.1523/JNEUROSCI.6244-10.2011 21813674
55. Progranulin enhances neural progenitor cell proliferation through glycogen synthase kinase 3beta phosphorylation. Nedachi T, Kawai T, Matsuwaki T, Yamanouchi K, N ishihara M, Neuroscience 2011 185 106 115 21540081
56. Increased caspase activation and decreased TDP-43 solubility in progranulin knockout cortical cultures. Kleinberger G, Wils H, Ponsaerts P, Joris G, Timmermans JP, Van Broeckhoven C, Kumar-Singh S, J Neurochem 2010 115 735 747 10.1111/j.1471-4159.2010.06961.x 20731760
57. Extracellular progranulin protects cortical neurons from toxic insults by activating survival signaling. Xu J, Xilouri M, Bruban J, Shioi J, Shao Z, Papazoglou I, Vekrellis K, Robakis NK, Neurobiol Aging 2011 32 2326 21820214
58. Functional genomic analyses identify pathways dysregulated by progranulin deficiency, implicating wnt signaling. Rosen EY, Wexler EM, Versano R, Coppola G, Gao F, Winden KD, Oldham MC, Martens LH, Zhou P, Farese RV Jr, Geschwind DH, Neuron 2011 71 1030 1042 10.1016/j.neuron.2011.07.021 21943601
59. Progranulin deficiency leads to enhanced cell vulnerability and TDP-43 translocation in primary neuronal cultures. Guo A, Tapia L, Bamji SX, Cynader MS, Jia W, Brain Res 2010 1366 1 8 20888804
60. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. Zhang YJ, Xu YF, Dickey CA, Buratti E, Baralle F, Bailey R, Pickering-Brown S, Dickson D, Petrucelli L, J Neurosci 2007 27 10530 10534 10.1523/JNEUROSCI.3421-07.2007 17898224 (Pubitemid 47501990)
61. Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin. Dormann D, Capell A, Carlson AM, Shankaran SS, Rodde R, Neumann M, Kremmer E, Matsuwaki T, Yamanouchi K, Nishihara M, Haass C, J Neurochem 2009 110 1082 1094 10.1111/j.1471-4159.2009.06211.x 19522733
62. Genome-wide screen identifies rs646776 near sortilin as a regulator of progranulin levels in human plasma. Carrasquillo MM, Nicholson AM, Finch N, Gibbs JR, Baker M, Rutherford NJ, Hunter TA, DeJesus-Hernandez M, Bisceglio GD, Mackenzie IR, Singleton A, Cookson MR, Crook JE, Dillman A, Hernandez D, Petersen RC, Graff-Radford NR, Younkin SG, Rademakers R, Am J Hum Genet 2010 87 890 897 10.1016/j.ajhg.2010.11.002 21087763
63. Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. Hu F, Padukkavidana T, Vaegter CB, Brady OA, Zheng Y, Mackenzie IR, Feldman HH, Nykjaer A, Strittmatter SM, Neuron 2010 68 654 667 10.1016/j.neuron.2010.09.034 21092856
64. VPS10P-domain receptors-regulators of neuronal viability and function. Willnow TE, Petersen CM, Nykjaer A, Nat Rev Neurosci 2008 9 899 909 10.1038/nrg2454 19002190 (Pubitemid 50319594)
65. C-terminus of progranulin interacts with the beta-propeller region of sortilin to regulate progranulin trafficking. Zheng Y, Brady OA, Meng PS, Mao Y, Hu F, PLoS One 2011 6 21023 10.1371/journal.pone.0021023 21698296
66. The Vps10p-domain receptor family. Hermey G, Cell Mol Life Sci 2009 66 2677 2689 10.1007/s00018-009-0043-1 19434368
67. Molecular identification of a novel candidate sorting receptor purified from human brain by receptor-associated protein affinity chromatography. Petersen CM, Nielsen MS, Nykjaer A, Jacobsen L, Tommerup N, Rasmussen HH, Roigaard H, Gliemann J, Madsen P, Moestrup SK, J Biol Chem 1997 272 3599 3605 10.1074/jbc.272.6.3599 9013611 (Pubitemid 27066865)
68. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ, Liu GY, Syed NM, Lai Y, Lin EA, Kong L, Su J, Yin F, Ding AH, Zanin-Zhorov A, Dustin ML, Tao J, Craft J, Yin Z, Feng JQ, Abramson SB, Yu XP, Liu CJ, Science 2011 332 478 484 10.1126/science.1199214 21393509
69. Alteration of behavioural phenotype in mice by targeted disruption of the progranulin gene. Kayasuga Y, Chiba S, Suzuki M, Kikusui T, Matsuwaki T, Yamanouchi K, Kotaki H, Horai R, Iwakura Y, Nishihara M, Behav Brain Res 2007 185 110 118 10.1016/j.bbr.2007.07.020 17764761 (Pubitemid 47633696)
70. Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging. Ahmed Z, Sheng H, Xu YF, Lin WL, Innes AE, Gass J, Yu X, Wuertzer CA, Hou H, Chiba S, Yamanouchi K, Leissring M, Petrucelli L, Nishihara M, Hutton ML, McGowan E, Dickson DW, Lewis J, Am J Pathol 2010 177 311 324 10.2353/ajpath.2010.090915 20522652
71. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. Yin F, Banerjee R, Thomas B, Zhou P, Qian L, Jia T, Ma X, Ma Y, Iadecola C, Beal MF, Nathan C, Ding A, J Exp Med 2010 207 117 128 10.1084/jem.20091568 20026663
72. Behavioral deficits and progressive neuropathology in progranulin-deficient mice: a mouse model of frontotemporal dementia. Yin F, Dumont M, Banerjee R, Ma Y, Li H, Lin MT, Beal MF, Nathan C, Thomas B, Ding A, FASEB J 2010 24 4639 4647 10.1096/fj.10-161471 20667979
73. A neurodegenerative disease mutation that accelerates the clearance of apoptotic cells. Kao AW, Eisenhut RJ, Martens LH, Nakamura A, Huang A, Bagley JA, Zhou P, de Luis A, Neukomm LJ, Cabello J, Farese RV Jr, Kenyon C, Proc Natl Acad Sci USA 2011 108 4441 4446 10.1073/pnas.1100650108 21368173
74. Progranulin modulates zebrafish motoneuron development in vivo and rescues truncation defects associated with knockdown of Survival motor neuron 1. Chitramuthu BP, Baranowski DC, Kay DG, Bateman A, Bennett HP, Mol Neurodegener 2010 5 41 10.1186/1750-1326-5-41 20946666
75. Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia. Cenik B, Sephton CF, Dewey CM, Xian X, Wei S, Yu K, Niu W, Coppola G, Coughlin SE, Lee SE, Dries DR, Almeida S, Geschwind DH, Gao FB, Miller BL, Farese RV Jr, Posner BA, Yu G, Herz J, J Biol Chem 2011 286 16101 16108 10.1074/jbc.M110.193433 21454553
76. Rescue of progranulin deficiency associated with frontotemporal lobar degeneration by alkalizing reagents and inhibition of vacuolar ATPase. Capell A, Liebscher S, Fellerer K, Brouwers N, Willem M, Lammich S, Gijselinck I, Bittner T, Carlson AM, Sasse F, Kunze B, Steinmetz H, Jansen R, Dormann D, Sleegers K, Cruts M, Herms J, Van Broeckhoven C, Haass C, J Neurosci 2011 31 1885 1894 10.1523/JNEUROSCI.5757-10.2011 21289198
77. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Van Deerlin VM, Sleiman PM, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M, Arnold SE, Mann DM, Pickering-Brown SM, Seelaar H, Heutink P, van Swieten JC, Murrell JR, Ghetti B, Spina S, Grafman J, Hodges J, Spillantini MG, Gilman S, Lieberman AP, Kaye JA, Woltjer RL, Bigio EH, Mesulam M, Al-Sarraj S, Troakes C, et al. Nat Genet 2010 42 234 239 10.1038/ng.536 20154673
78. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Finch N, Carrasquillo MM, Baker M, Rutherford NJ, Coppola G, Dejesus-Hernandez M, Crook R, Hunter T, Ghidoni R, Benussi L, Crook J, Finger E, Hantanpaa KJ, Karydas AM, Sengdy P, Gonzalez J, Seeley WW, Johnson N, Beach TG, Mesulam M, Forloni G, Kertesz A, Knopman DS, Uitti R, White CL, Caselli R, Lippa C, Bigio EH, Wszolek ZK, Binetti G, et al. Neurology 2011 76 467 474 10.1212/WNL.0b013e31820a0e3b 21178100
79. Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels. Cruchaga C, Graff C, Chiang HH, Wang J, Hinrichs AL, Spiegel N, Bertelsen S, Mayo K, Norton JB, Morris JC, Goate A, Arch Neurol 2011 68 581 586 10.1001/archneurol.2010.350 21220649
80. Frontotemporal lobar degeneration genome wide association study replication confirms a risk locus shared with amyotrophic lateral sclerosis. Rollinson S, Mead S, Snowden J, Richardson A, Rohrer J, Halliwell N, Usher S, Neary D, Mann D, Hardy J, Pickering-Brown S, Neurobiol Aging 2011 32 758 e751-e757 21257233